<DOC>
	<DOC>NCT02929524</DOC>
	<brief_summary>Randomized clinical trial, controlled, double-blind, parallel two-arm.</brief_summary>
	<brief_title>Intranasal Ketamine as a Sedative for Venipuncture</brief_title>
	<detailed_description>Randomized, double-blind, placebo controlled study conducted at the Clinical Hospital of Porto Alegre between November / 15 and August / 16. This study was approved by the Ethics Committee of the Institution. Participated children requiring venipuncture randomized in the intervention group who received the ketamine IN 4 mg/kg and placebo saline group. The groups were compared: Puncture time, ease the nurse to perform the procedure, adverse events, changes in vital signs and perception of the companion.</detailed_description>
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Respiratory Tract Diseases</mesh_term>
	<mesh_term>Digestive System Diseases</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Hypnotics and Sedatives</mesh_term>
	<criteria>Children hospitalized in the Pediatric Inpatient Units, with the presence of legal guardian; Aged 3 months to 12 years; Requiring venipuncture independent research. Severe neurological sequelae; Patients who need immediate venipuncture at risk; Presence of active nosebleeds; Patients using drugs sedative and analgesic continuos; Children who have experienced clinical change with ketamine.</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Ketamine</keyword>
	<keyword>Intranasal administration</keyword>
	<keyword>Pediatric nursing</keyword>
</DOC>